Last 12 months
Inside the activity.
0 purchase rows · 116 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 20 |
| Dec 2025 | 0 | 15 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 23 |
| May 2026 | 0 | 22 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2019 Filed May 22, 2019 00:10 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 3,000 | $0.93 | $2,790.00 |
DisclosureSEC source: 0000898432-19-000866 · form4.xml · nonDerivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| May 20, 2019 Filed May 22, 2019 00:10 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-000866 · form4.xml · derivative · entry 8 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,775 Underlying: Common Stock · 2,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| May 20, 2019 Filed May 22, 2019 00:10 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 2,000 | $22.53 | $45,060.00 |
DisclosureSEC source: 0000898432-19-000866 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $22.53 to $22.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 20, 2019 Filed May 22, 2019 00:10 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 2,000 | $0.93 | $1,860.00 |
DisclosureSEC source: 0000898432-19-000866 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| May 17, 2019 Filed May 22, 2019 00:10 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-000866 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,775 Underlying: Common Stock · 3,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| May 17, 2019 Filed May 22, 2019 00:10 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 3,000 | $21.83 | $65,490.00 |
DisclosureSEC source: 0000898432-19-000866 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.21 to $22.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 17, 2019 Filed May 22, 2019 00:10 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 3,000 | $0.93 | $2,790.00 |
DisclosureSEC source: 0000898432-19-000866 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| April 27, 2019 Filed Apr 30, 2019 18:36 UTC |
McCreery John KChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-000796 · form4.xml · derivative · entry 3 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan and pursuant to the reporting person's employment agreement with Iradimed Corporation. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan and pursuant to the reporting person's employment agreement with Iradimed Corporation. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| April 27, 2019 Filed Apr 30, 2019 18:36 UTC |
McCreery John KChief Operating Officer
|
Tax withholdingCommon Stock | 3,797 | $29.31 | $111,290.07 |
DisclosureSEC source: 0000898432-19-000796 · form4.xml · nonDerivative · entry 2 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,011 Read SEC document |
| April 27, 2019 Filed Apr 30, 2019 18:36 UTC |
McCreery John KChief Operating Officer
|
Exercise / conversionCommon Stock | 15,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-000796 · form4.xml · nonDerivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 28, 2019 Filed Mar 29, 2019 22:18 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,644 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-000579 · form4.xml · derivative · entry 2 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,644 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On March 28, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vested in three equal annual installments beginning on March 28, 2017. Upon vesting, the reporting person received a number of shares of common stock equal to the number of restricted stock units that had vested. F2 · derivative.expiration_date: On March 28, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vested in three equal annual installments beginning on March 28, 2017. Upon vesting, the reporting person received a number of shares of common stock equal to the number of restricted stock units that had vested. Read SEC document |
| March 28, 2019 Filed Mar 29, 2019 22:18 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionCommon Stock | 2,644 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-000579 · form4.xml · nonDerivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:15 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,671 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-000397 · form4.xml · derivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,775 Underlying: Common Stock · 7,671 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:15 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
SaleCommon Stock | 7,671 | $25.05 | $192,193.84 |
DisclosureSEC source: 0000898432-19-000397 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F2 · price: This transaction was executed in multiple trades at prices ranging from $25.0 to $25.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:15 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
GrantCommon Stock | 7,671 | $0.93 | $7,134.03 |
DisclosureSEC source: 0000898432-19-000397 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,039 Read SEC document |
| March 13, 2019 Filed Mar 18, 2019 20:15 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 52,492 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-000397 · form4.xml · derivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,446 Underlying: Common Stock · 52,492 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| March 13, 2019 Filed Mar 18, 2019 20:15 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
SaleCommon Stock | 52,492 | $24.42 | $1,281,644.67 |
DisclosureSEC source: 0000898432-19-000397 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · price: This transaction was executed in multiple trades at prices ranging from $24.325 to $24.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 13, 2019 Filed Mar 18, 2019 20:15 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
GrantCommon Stock | 52,492 | $0.93 | $48,817.56 |
DisclosureSEC source: 0000898432-19-000397 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,860 Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 21:05 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,658 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-000377 · form4.xml · derivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,938 Underlying: Common Stock · 3,658 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 21:05 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 3,658 | $25.00 | $91,462.07 |
DisclosureSEC source: 0000898432-19-000377 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F2 · price: This transaction was executed in multiple trades at prices ranging from $25.0 to $25.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 21:05 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 3,658 | $0.93 | $3,401.94 |
DisclosureSEC source: 0000898432-19-000377 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,026 Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 21:05 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,033 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-000377 · form4.xml · derivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,596 Underlying: Common Stock · 17,033 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 21:05 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 17,033 | $25.38 | $432,297.54 |
DisclosureSEC source: 0000898432-19-000377 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · price: This transaction was executed in multiple trades at prices ranging from $25.0 to $26.125. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 21:05 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 17,033 | $0.93 | $15,840.69 |
DisclosureSEC source: 0000898432-19-000377 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,401 Read SEC document |
| March 07, 2019 Filed Mar 8, 2019 02:09 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,614 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-000370 · form4.xml · derivative · entry 9 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,629 Underlying: Common Stock · 7,614 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| March 07, 2019 Filed Mar 8, 2019 02:09 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 7,614 | $24.52 | $186,712.79 |
DisclosureSEC source: 0000898432-19-000370 · form4.xml · nonDerivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F3 · price: This transaction was executed in multiple trades at prices ranging from $24.5 to $24.6. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 07, 2019 Filed Mar 8, 2019 02:09 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 7,614 | $0.93 | $7,081.02 |
DisclosureSEC source: 0000898432-19-000370 · form4.xml · nonDerivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,962 Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 17:12 UTC |
Waldman Louis S.Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $9.84 | $0.00 |
DisclosureSEC source: 0000898432-19-000375 · form4.xml · derivative · entry 4 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2024-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on 12/15/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 17:12 UTC |
Waldman Louis S.Controller
|
SaleCommon Stock | 15,000 | $24.27 | $364,104.00 |
DisclosureSEC source: 0000898432-19-000375 · form4.xml · nonDerivative · entry 2 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,005 F1 · price: This transaction was executed in multiple trades at prices ranging from $24.25 to $24.365. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 17:12 UTC |
Waldman Louis S.Controller
|
GrantCommon Stock | 15,000 | $9.84 | $147,600.00 |
DisclosureSEC source: 0000898432-19-000375 · form4.xml · nonDerivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,005 Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 02:09 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,672 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-000370 · form4.xml · derivative · entry 8 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,243 Underlying: Common Stock · 9,672 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 02:09 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 9,672 | $24.58 | $237,770.64 |
DisclosureSEC source: 0000898432-19-000370 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F2 · price: This transaction was executed in multiple trades at prices ranging from $24.5 to $24.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 02:09 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 9,672 | $0.93 | $8,994.96 |
DisclosureSEC source: 0000898432-19-000370 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,040 Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 21:50 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $9.84 | $0.00 |
DisclosureSEC source: 0000898432-19-000365 · form4.xml · derivative · entry 3 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 10,000 shares, was granted on 12/15/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 21:50 UTC |
ALLEN MONTY KDirector
|
SaleCommon Stock | 10,000 | $25.39 | $253,945.00 |
DisclosureSEC source: 0000898432-19-000365 · form4.xml · nonDerivative · entry 2 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,663 F1 · price: This transaction was executed in multiple trades at prices ranging from $25.25 to $25.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 21:50 UTC |
ALLEN MONTY KDirector
|
GrantCommon Stock | 10,000 | $9.84 | $98,400.00 |
DisclosureSEC source: 0000898432-19-000365 · form4.xml · nonDerivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,663 Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:09 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,860 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-000370 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,915 Underlying: Common Stock · 1,860 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:09 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 1,860 | $25.43 | $47,292.55 |
DisclosureSEC source: 0000898432-19-000370 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · price: This transaction was executed in multiple trades at prices ranging from $25.3 to $25.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:09 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 1,860 | $0.93 | $1,729.80 |
DisclosureSEC source: 0000898432-19-000370 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,228 Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 16:45 UTC |
Nardi Steven M.VP MANUFACTURING
|
SaleCommon Stock | 1,418 | $26.07 | $36,961.16 |
DisclosureSEC source: 0000898432-19-000364 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.135. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:59 UTC |
Casey Francis X.VP OF REG AND QUAL ASSURANCE
|
Exercise / conversionRestricted Stock Units · Derivative | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-000014 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:59 UTC |
Casey Francis X.VP OF REG AND QUAL ASSURANCE
|
Tax withholdingCommon Stock | 95 | $24.46 | $2,323.70 |
DisclosureSEC source: 0000898432-19-000014 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,005 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:59 UTC |
Casey Francis X.VP OF REG AND QUAL ASSURANCE
|
Exercise / conversionCommon Stock | 388 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-000014 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP OF REG AND QUAL ASSURANCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 18:06 UTC |
Waldman Louis S.Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 1,164 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-000016 · form4.xml · derivative · entry 4 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,164 Underlying: Common Stock · 1,164 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 18:06 UTC |
Waldman Louis S.Controller
|
Tax withholdingCommon Stock | 284 | $24.46 | $6,946.64 |
DisclosureSEC source: 0000898432-19-000016 · form4.xml · nonDerivative · entry 2 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,005 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 18:06 UTC |
Waldman Louis S.Controller
|
Exercise / conversionCommon Stock | 1,164 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-000016 · form4.xml · nonDerivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:52 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionRestricted Stock Units · Derivative | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-000013 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388 Underlying: Common Stock · 388 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:52 UTC |
Nardi Steven M.VP MANUFACTURING
|
Tax withholdingCommon Stock | 95 | $24.46 | $2,323.70 |
DisclosureSEC source: 0000898432-19-000013 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,418 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:52 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionCommon Stock | 388 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-000013 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 23:07 UTC |
JOHNSON BRENTExec. VP. Sales & Marketing
|
Exercise / conversionRestricted Stock Units · Derivative | 617 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-000017 · form4.xml · derivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617 Underlying: Common Stock · 617 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.